NCT00777972View on ClinicalTrials.gov

Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions

NACompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

April 30, 2003

Conditions
Healthy
Interventions
DRUG

Fosinopril sodium and hydrochlorothiazide 20-12.5 mg tablets

Trial Locations (1)

63301

Gateway Medical Research Inc, Saint Charles

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00777972 - Bioequivalence Study of Fosinopril Sodium/ Hydrochlorothiazide 20/ 12.5 mg Tablets Under Fasting Conditions | Biotech Hunter | Biotech Hunter